Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan · Delayed Price · Currency is TWD 125.00
-2.00 (-1.57%)
Nov 21, 2025, 2:38 PM CST
TPE:6919 Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Net Income | -488.25 | -588.83 | -488.46 | -286.16 | -224.29 | -98.49 | Upgrade |
Depreciation & Amortization | 30.28 | 29.51 | 27.87 | 25.34 | 23.28 | 18.21 | Upgrade |
Loss (Gain) From Sale of Assets | - | - | - | 0.11 | - | - | Upgrade |
Stock-Based Compensation | 118.05 | 65.05 | 22.98 | 19.71 | 74.76 | 8.28 | Upgrade |
Other Operating Activities | -36.38 | -6.69 | -0.35 | -0.36 | -3.27 | 0.86 | Upgrade |
Change in Accounts Receivable | 9.8 | 2.71 | -4.77 | -3.12 | - | 3.2 | Upgrade |
Change in Inventory | -2.11 | -1.84 | 1.78 | -2.76 | 2.48 | -2.51 | Upgrade |
Change in Accounts Payable | -3.23 | -0.73 | -0.83 | 2.21 | -0.41 | -0.3 | Upgrade |
Change in Unearned Revenue | 1.73 | 2.59 | -3.47 | 4.5 | - | - | Upgrade |
Change in Other Net Operating Assets | -36.8 | -24.08 | 21.32 | -2.22 | 16.77 | 23.51 | Upgrade |
Operating Cash Flow | -406.91 | -522.31 | -423.94 | -242.76 | -110.7 | -47.24 | Upgrade |
Capital Expenditures | -12.91 | -10 | -8.6 | -14.16 | -14.9 | -2.31 | Upgrade |
Sale of Property, Plant & Equipment | - | - | - | 0 | - | - | Upgrade |
Sale (Purchase) of Intangibles | -0.61 | -1.09 | -1.09 | - | - | - | Upgrade |
Investment in Securities | -5,606 | -2,478 | 166.78 | -456.18 | - | - | Upgrade |
Other Investing Activities | -4.41 | - | 0.01 | -0.2 | - | - | Upgrade |
Investing Cash Flow | -5,624 | -2,489 | 157.09 | -470.54 | -14.9 | -2.31 | Upgrade |
Long-Term Debt Issued | - | - | - | - | - | 8.13 | Upgrade |
Total Debt Issued | - | - | - | - | - | 8.13 | Upgrade |
Short-Term Debt Repaid | - | - | - | - | - | -5 | Upgrade |
Long-Term Debt Repaid | - | -8.58 | -8.22 | -12.6 | -93.98 | -27.83 | Upgrade |
Total Debt Repaid | -8.83 | -8.58 | -8.22 | -12.6 | -93.98 | -32.83 | Upgrade |
Net Debt Issued (Repaid) | -8.83 | -8.58 | -8.22 | -12.6 | -93.98 | -24.7 | Upgrade |
Issuance of Common Stock | 64.08 | 6,499 | 3,042 | 784.32 | 720.88 | 147.43 | Upgrade |
Repurchase of Common Stock | - | - | - | - | -0.09 | - | Upgrade |
Other Financing Activities | -23.48 | 0.52 | - | - | - | - | Upgrade |
Financing Cash Flow | 31.77 | 6,491 | 3,034 | 771.72 | 626.81 | 122.74 | Upgrade |
Foreign Exchange Rate Adjustments | -25.99 | -0.11 | 0.32 | 1.73 | 0.14 | -1.32 | Upgrade |
Net Cash Flow | -6,025 | 3,479 | 2,767 | 60.15 | 501.35 | 71.87 | Upgrade |
Free Cash Flow | -419.82 | -532.31 | -432.54 | -256.93 | -125.6 | -49.55 | Upgrade |
Free Cash Flow Margin | -1199.83% | -1197.97% | -1111.01% | -2004.12% | -1017.90% | -478.70% | Upgrade |
Free Cash Flow Per Share | -0.27 | -0.37 | -0.35 | -0.22 | -0.14 | -0.07 | Upgrade |
Cash Interest Paid | 0.2 | 0.33 | 0.5 | 0.67 | 6.18 | 3.65 | Upgrade |
Cash Income Tax Paid | - | - | - | - | 0.03 | 0.09 | Upgrade |
Levered Free Cash Flow | -375.46 | -391.26 | -266.4 | -171.06 | -74 | -19.88 | Upgrade |
Unlevered Free Cash Flow | -375.33 | -391.05 | -266.09 | -170.65 | -72.19 | -17.06 | Upgrade |
Change in Working Capital | -30.61 | -21.35 | 14.03 | -1.4 | 18.84 | 23.9 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.